Place two packs of CBD seeds next to each other, one labelled 1:1 and the other 20:1, and the two look the same: the same brand packaging, same seed count, contents which nobody’s eye can separate apart. Grow them in the same tent and they go their separate ways at the first stage and do not converge again. The cause is one single gene, and the clearest way to understand what it does is to follow the two packs through each stage they share: the cross that made them, the seed, the seedling, the flower room, the harvest, the jar, the lab report and the border. The ratios quoted as reference points throughout are drawn from the range at https://calmcbdseeds.com, which goes 1:1, 2:1 and 20:1 and a top line at about 30 to one; the biology holds the same regardless of which shop the packs came from.
Stage One: At the Breeder’s Bench
Cannabis decides if it is going to make THC or CBD at one locus on the genome. The gene there comes in two forms: one codes the enzyme that converts the common precursor into THCA, the other the enzyme that converts it into CBDA. Each plant holds two copies, one received from either parent, and the combination sets the chemotype. Two THC copies give a THC-dominant plant. Two CBD copies give a CBD-dominant one. One of each gives a balanced plant, because the two forms are codominant and not one of them overrides the other.
The balanced pack was made by crossing two balanced plants, both carrying one copy of each form. The 20:1 pack was bred by crossing two plants which each carry two CBD copies and not a single THC copy between them. That one fact at the cross decides everything afterwards, and the difference is already in the seed before it is put in the foil.
The Mendelian Split
Cross two balanced plants and the seeds sort out by the oldest arithmetic in genetics: a quarter inherit two THC copies, a quarter get two CBD copies, half get one of each. In a pack of 10 seeds that means, on average, two or three THC-dominant seeds, two or three CBD-dominant ones, and five true balanced seeds. The pack is sold by its parents, and for half its seeds the label is accurate; for the other half it does not. Calm CBD Seeds prints the expected split on every balanced pack, so the buyer sees before sowing that a share of the plants are going to differ from the headline ratio.
The 20:1 pack has no such split. Every seed got a CBD copy from both parent, each plant will be CBD-dominant, and the ratio on the foil holds to all of them, within the ordinary variation in how much total cannabinoid an individual plant builds. Breeders describe such lines „breed true“ for chemotype; the phrase means exactly this lack of surprise.
Where Nothing Shows
At this stage the two packs appear alike again, and the likeness lasts longer than many growers assume. Chemotype leaves no mark on a seedling. Leaf, colour, stem spacing and growth are controlled by different genes entirely, and the three chemotypes of plant in the balanced pack grow without any visible difference from one another and from every plant in the 20:1 pack.
The one practical difference during this stage arises from ancestry not chemotype. Strains with recent hemp ancestry, and that covers some less developed CBD-dominant lines, are inclined to grow rangier and fill out more sparsely. A well-worked 20:1 line behaves like any indoor hybrid; a early-generation one may still shows the hemp in its frame. Not one of these habit tells a thing about the ratio in the flower.
Frost, Smell and the Wrong Conclusions
In flower the two packs begin to give hints, and most of them mislead. Resin density is the usual one a grower judges, and it used to be a reasonable guide: early CBD-dominant strains carried visibly less frost than their THC cousins, a legacy from hemp. Modern lines have largely closed that gap, and a lightly resinous plant from the 20:1 pack can perfectly well come in precisely where the foil promised. Trichome density and chemotype are carried on separate genes.
Smell is an even poorer guide. The terpene profile lives on yet other genes, so the THC-dominant plant sitting in the balanced pack can be indistinguishable to the balanced one beside it, and both can smell identical to a plant from the 20:1 pack. Growers who attempt to sort a balanced pack by nose in week eight are right about half the time, which is not better than not sorting at all.
Stage Five: The Harvest Window
At this stage the two packs differ in a way that benefits the grower of the 20:1 pack and also the CBD-dominant plants hidden in the balanced pack. CBDA degrades more slowly than THCA, so a CBD-dominant plant allowed a week beyond its peak keeps most of its cannabinoid load, whereas a THC-dominant one under the same conditions has by then started converting THC to CBN. The cloudy guidance nonetheless applies; it applies because the terpenes, which fade on every plant regardless the chemotype, and a late, over-dried CBD flower tastes of very little whatever the test result says.
Stage Six: The Jar
The 20:1 pack goes into one jar. Each plant in it carries about the same ratio, and blending them alters nothing worth measuring. The balanced pack cannot be treated the same way. Blend its 10 plants into a single jar and the contents is a mixture that nobody’s foil could have promised, skewed by whichever plants yielded most, and nothing on a later test can untangle what went in.
The discipline that prevents the grief is almost tedious: harvest the balanced pack plant by plant, dry each separately, number them, and test them plant at a time before anything is combined. It is the one point in the whole process where the three kinds of plant in the balanced pack can yet be kept apart without a lab, and then only for the reason that every one is at that moment in its own bag.
Stage Seven: The Lab Report
Submit a sample from each jar to a laboratory and the two packs finally become legible. For the 20:1 pack the certificates arrive back grouped closely near the advertised ratio, varying mostly in total cannabinoid content not in balance. For the balanced pack they arrive back in three clusters: a few plants with almost all THC, some with nearly all CBD, and the rest somewhere around one to one. Nothing of this result is a failure; it is the bench cross written out as numbers.
Over-the-counter test kits are sold for growers who cannot reach a lab, and the majority of them show whether THC is there but not how much. That is enough to pull the THC-dominant jars away from a balanced pack and not enough to assign a ratio to the rest, and that matches the commonest need: finding out which of the 10 jars is going to surprise someone.
Hemp Threshold Versus Chemotype
The last place at which the two packs diverge is in law, and it catches growers who assumed „CBD“ was shorthand for „hemp“. The majority of countries classify hemp by a THC limit, a small fraction of a percent of dry weight, with the precise number differing from country and over time. A plant from the 20:1 pack producing twenty percent CBD at twenty to one at the same time makes around one percent THC, which is many times above the majority of thresholds. Compliant lines are selected to hold total cannabinoid content down so the THC share remains below the line right up to harvest; CBD seed lines are selected for high output and let the THC rise with it. A seller that gives only a ratio is describing a flower line; anyone who requires a legal hemp crop needs to look for a tested THC figure at maturity and order no line that does not provide one.
Past the threshold issue, the word on the foil alters very little in the law on the seed as such. Where holding cannabis seeds is lawful and germinating them is not, the balanced pack and the 20:1 pack fall in the same rule as any other pack. In places where the plant is legal without restriction, the choice between them is a matter of preference and nobody else’s. None of this article is legal advice, and the rule which applies is the one where the seed is going to be grown, rather than the one where it was sold.